Group | OR1 | ||
---|---|---|---|
 | TF | Tn | Menopausal Status |
All Subjects | Â | Â | Â |
AbNL vs. Benign | 3.29* (1.29, 8.36) | .81 (.33, 2.0) | 2.19 (.95, 5.04) |
CA vs, Benign | 3.25* (1.27, 8.3) | .84 (.34, 2.07) | 2.23 (.96, 5.2) |
CA vs. No CA | 2.57* (1.10, 5.98) | .82 (.32, 1.76) | 2.0 (.91, 4.39) |
 | OR 1 | ||
 | TF | Tn | Age |
Premenopausal | Â | Â | Â |
AbNL vs. Benign | .96 (.27, 3.39) | 1.70 (.37, 7.81) | 1.13** (1.03, 1.24) |
CA vs, Benign | .86 (.23, 3.18) | 1.72 (.36, 8.16) | 1.17** (1.05, 1.30) |
CA vs. No CA | .83 (.24, 2.84) | 1.71 (.39, 7.48) | 1.15** (1.04, 1.26) |
Postmenopausal | Â | Â | Â |
AbNL vs. Benign | 15.56** (2.39, 101.2) | .35 (.09, 1.38) | 1.09* (1.01, 1.18) |
CA vs, Benign | 13.27** (2.08, 84.63) | .35 (.09, 1.38) | 1.09* (1.02, 1.18) |
CA vs. No CA | 8.53** (1.78, 40.74) | .32 (.09, 1.17) | 1.10** (1.02, 1.18) |